CK Pharma Support
Board
1 director, no change since 2023Director (not named in the articles)
appointed by deed of 03-10-2018
term without a fixed end
listed in the 2025 annual accounts, filed on 16-03-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 30-10-2023
1 name is hidden.
Create a free account or sign in to see the name.
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Manager, appointed by deed of 03-10-2018, until 30-10-2023
- Director (not named in the articles), since before 30-10-2023
1 name is hidden.
Create a free account or sign in to see the name.
Control
Founders
,
This company
CK Pharma Support
Equity €20,460
Profit €66,578 in 2025
2 names are hidden.
Create a free account or sign in to see the names.
Capital
- Contribution
- €18,600
- Shares
- 100
- Contribution per share
- €186
- Equity per share
- €205 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 30-10-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Tuesday of June at 20:00
Shareholders
At incorporation
deed of 03-10-2018 ↗
- 50 shares (50%)
- 50 shares (50%)
2 names are hidden.
Create a free account or sign in to see the names.
Capital transactions
Capital over time
- 30-10-2023 Converted to unavailable equity · €20,460
- 03-10-2018 Incorporation · €18,600 · 100 shares